8:01 AM ET
10-Q
Financial Results
Artelo Biosciences Q3 2026 Results: Net Loss of $1.77M, Loss Narrows
Artelo Biosciences reported a net loss of $7.15 million for the nine months ended September 30, 2026, compared to $8.71 million in the prior year period. The company strengthened its balance sheet through equity financing, ending the quarter with $4.44 million in cash and cash equivalents, up from $0.6 million at the start of the year.
- Key figure
- Net loss $1.77M